Buechel, Ronny R.
Ciancone, Domenico
Bakula, Adam
von Felten, Elia
Schmidt, Gian-Andrea
Patriki, Dimitri
Gräni, Christoph
Wahl, Andreas
Manka, Robert
Heidecker, Bettina
Benz, Dominik C.
Giannopoulos, Andreas A.
Pazhenkottil, Aju P.
Kaufmann, Philipp A.
Funding for this research was provided by:
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (Project No. 175640)
University of Zurich
Article History
Received: 17 March 2023
Accepted: 17 June 2023
First Online: 1 July 2023
Declarations
:
: Informed consent was obtained from all individual participants included in the study.
: The authors affirm that human research participants provided informed consent for the publication of the images in Figs. InternalRef removed and InternalRef removed.
: The University Hospital Zurich holds a research agreement with GE Healthcare. RRB received speaker honoraria from GE Healthcare, IBA, Gilead and Pfizer. BH is inventor on patents that use RNA for diagnosis of myocarditis. Patent protection is in process for MCG for diagnosis and measurement of therapy response in inflammatory cardiomyopathy.